Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis?
Corrado Campochiaro, Yannick Allanore, Yolanda Braun‐Moscovici, Marco Matucci‐Cerinic, Alexandra Balbir‐Gurman
Topics & Concepts
MedicineTocilizumabRituximabCyclophosphamideAdverse effectInterstitial lung diseaseConcomitantAzathioprineIntensive care medicineInternal medicineRandomized controlled trialGold standard (test)OncologyDiseaseChemotherapyLymphomaLungSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInflammatory Myopathies and Dermatomyositis